Medical Condition News

RSS

Sanofi-Aventis acquires exclusive global rights to CureDM's Pancreate

CureDM, LLC announced today that an agreement has been signed with Sanofi-Aventis for the exclusive worldwide license of Pancreate™, a novel islet neogenesis agent for the treatment of type 1 and type 2 diabetes. CureDM is a privately held biopharmaceutical company whose scientists discovered Pancreate™, a first-in-class human peptide therapeutic. Several key Composition of Matter and Use patents have been issued to CureDM for this potentially transforming treatment approach for diabetes.

9 Apr 2010

Keryx Biopharmaceuticals commences Phase 3 registration clinical trial for perifosine

Keryx Biopharmaceuticals, Inc. announced today the initiation of a Phase 3 registration clinical trial for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of patients with refractory advanced colorectal cancer.

9 Apr 2010

University of Southampton, Synairgen Research scientists commence Phase II trial of interferon beta for asthma

Scientists from the University of Southampton and Synairgen Research Ltd, a respiratory drug development company spun out from the University, have begun a Phase II study into the effectiveness of the drug interferon beta for asthma patients.

9 Apr 2010

Cell Therapeutics receives FDA Complete Response Letter for Pixuvri NDA

Cell Therapeutics, Inc. today announced that it had received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for Pixuvri™ (pixantrone dimaleate) for relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL").

9 Apr 2010

ReVision Optics initiates US clinical trial of PresbyLens corneal inlay

ReVision Optics, a leading company in the research, development and manufacture of custom optical products to correct and maintain vision, announced today that it has begun its US clinical trial of the PresbyLens® corneal inlay. The clinical trial will evaluate the PresbyLens® corneal inlay for the correction of presbyopia, the age-related loss of near vision. The study began on April 6th with the treatment of three subjects by clinical investigator Dr. Stephen Slade of the Slade & Baker Vision Center in Houston, Texas.

9 Apr 2010

Æterna Zentaris commences perifosine Phase 3 registration trial

Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced the initiation of a Phase 3 registration clinical trial with perifosine (KRX-0401) ), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.

9 Apr 2010

Raised levels of carbon dioxide in blood may lead to ‘near death experiences’

Near death experiences (NDEs), reported to include sensations such as life flashing before the eyes, feelings of peace and joy, and apparent encounters with mystical entities, may be caused by raised levels of carbon dioxide in the blood. Researchers writing in BioMed Central's open access journal Critical Care investigated the unexplained events in 52 cardiac arrest patients.

8 Apr 2010

WTC FDNY Rescue Workers have not recovered normal lung function, yet

A study of nearly 13,000 rescue workers from the Fire Department of the City of New York (FDNY) shows that the significant proportion who suffered acute lung damage after exposure to World Trade Center (WTC) dust have not recovered normal lung function in the years since the September 11, 2001 terrorist attacks.

8 Apr 2010

Dealing with emotional impacts of bullying before it's too late

The California Association of Marriage and Family Therapists (CAMFT) encourages parents to talk with teens about bullying before it's too late. A conversation can be an important first step in identifying a bullying problem and stopping the abuse before it goes too far.

8 Apr 2010

Whey Protein Isolate damages and accelerates hair loss

Dr. Larry Shapiro, a nationally recognized hair transplant surgeon and dermatologist in South Florida, announced today the results of a study that compared the Effects of Whey Protein Concentrate (WPC) to Whey Protein Isolate (WPI) on Hair, which suggests that WPI, an ingredient found in many popular weight loss, meal replacement and body building products, is contributing to hair loss.

8 Apr 2010

Crohn's disease: Remicade prescription to decrease, while Humira's increases

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed gastroenterologists estimate that (assuming no new data on adverse events emerge) they will treat fewer Crohn's disease patients with Centocor Ortho Biotech/Merck/Mitsubishi Tanabe's Remicade by the end of 2010, while the percentage of biologics-treated patients receiving Abbott/Eisai's Humira will increase to 36 percent.

8 Apr 2010

Combining antiangiogenic cancer therapy with oncolytic virotherapy leads to regression of tumors

Oncolytics Biotech Inc. announced today that a paper entitled "Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice," co-senior authored by Dr. Richard Vile of the Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA, and Dr. Kevin Harrington of the Institute of Cancer Research, London, UK, was published in the online version of the Journal of Clinical Investigation on April 1, 2010.

8 Apr 2010

Obese patients may receive higher rate of recommended care than normal-weight patients, but not lower

Despite a concern that obese or overweight patients may receive lower quality of health care, an analysis of eight common outpatient quality measures from a sample of nearly 70,000 patients finds no evidence that obese or overweight patients receive inferior care when compared with normal-weight patients, and in fact may receive a higher rate of recommended care on several measures, according to a study in the April 7 issue of JAMA.

8 Apr 2010

Allergy flare-ups due to indoor allergens

Spring is here and allergy flare-ups are often attributed to the allergens outside your front door. However, did you know that the same allergens are found on surfaces inside 75 million homes across America? According to the Centers for Disease Control and Prevention (CDC), some of the most common indoor allergens include dust mites, mold and household pets.

8 Apr 2010

No risk of adverse interaction between PPIs and clopidogrel

New research by the University of East Anglia (UEA) shows no risk in combining two commonly-prescribed treatments for patients at risk of heart attacks and strokes.

8 Apr 2010

Diabetic Connect moved onto Alliance Health Networks' new social networking platform

Alliance Health Networks has moved Diabetic Connect onto its new advanced social networking platform where Alliance Health's newer properties like Sleep Connect, Health Exchange, Arthritis Connect and several other health-focused social networking sites now operate.

8 Apr 2010

Reliable immune monitoring tool for assessment of cancer vaccine-induced CD4+ T-cell response

A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool that allows for more accurate measurement of the number, subtype, and activity of cancer antigen-specific CD4+ T cells in cancer patients treated with therapeutic cancer vaccines. The new technology may significantly aid tumor immunologists around the world who are working to improve the effectiveness of this emerging and highly promising class of immune system-based cancer therapies.

8 Apr 2010

Smoking may increase risk of MS in people who have established risk factors for MS

A new study shows that smoking may increase the risk of multiple sclerosis in people who also have specific established risk factors for MS. The research is found in the April 7, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology.

8 Apr 2010

Food-grade hydrogel helps reduce desire for food in obese patients

New research indicates that a first-of-its-kind, superabsorbent hydrogel significantly increased the post-meal feeling of satiety and reduced hunger between meals in obese patients. This data will be presented Thursday, April 22, 2010 at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting & Clinical Congress.

8 Apr 2010

Scientific evidence links high levels of copper and iron to age-related disorders

With scientific evidence linking high levels of copper and iron to Alzheimer's disease, heart disease, and other age-related disorders, a new report in ACS' Chemical Research in Toxicology suggests specific steps that older consumers can take to avoid build up of unhealthy amounts of these metals in their bodies.

8 Apr 2010

Medical Condition News

Sanofi-Aventis acquires exclusive global rights to CureDM's Pancreate

Keryx Biopharmaceuticals commences Phase 3 registration clinical trial for perifosine

University of Southampton, Synairgen Research scientists commence Phase II trial of interferon beta for asthma

Cell Therapeutics receives FDA Complete Response Letter for Pixuvri NDA

ReVision Optics initiates US clinical trial of PresbyLens corneal inlay

Æterna Zentaris commences perifosine Phase 3 registration trial

Raised levels of carbon dioxide in blood may lead to ‘near death experiences’

WTC FDNY Rescue Workers have not recovered normal lung function, yet

Dealing with emotional impacts of bullying before it's too late

Whey Protein Isolate damages and accelerates hair loss

Crohn's disease: Remicade prescription to decrease, while Humira's increases

Combining antiangiogenic cancer therapy with oncolytic virotherapy leads to regression of tumors

Obese patients may receive higher rate of recommended care than normal-weight patients, but not lower

Allergy flare-ups due to indoor allergens

No risk of adverse interaction between PPIs and clopidogrel

Diabetic Connect moved onto Alliance Health Networks' new social networking platform

Reliable immune monitoring tool for assessment of cancer vaccine-induced CD4+ T-cell response

Smoking may increase risk of MS in people who have established risk factors for MS

Food-grade hydrogel helps reduce desire for food in obese patients

Scientific evidence links high levels of copper and iron to age-related disorders

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News